About 38 million people worldwide are living with AIDS. Pharmaceutical treatments can keep the disease in check, but a vaccine remains elusive despite decades of concerted effort. However, a recent discovery at the Duke Human Vaccine Institute (DHVI) brings the goal of an effective vaccine within reach.

The National Institutes of Health (NIH) has awarded Susan D.

National breast cancer organization Susan G. Komen announced, on Sept.

Duke University is one of three sites that have been awarded a total of $4.4 million National Institutes of Health/National Cancer Institute Cancer Intervention and Surveillance Modeling Network (C

On October 8, the FDA approved a regenerative medicine based on Louise Markert, M.D., Ph.D.'s,  pioneering work as the only therapy

Every great exploration refines the map, and in the case of the massive BRAIN initiative funded by the National Institutes of Health, that new draft of the map has just been released.

Although Black lung cancer patients are more likely to die from their disease than white patients, they have better outcomes than whites when treated with immunotherapies that are now considered th

The National Institutes of Health (NIH) has awarded grants to three Duke University School of Medicine faculty members through the NIH Common Fund’s High-Risk, High-Reward Research program.

One day when Carol Deane was an undergraduate biology student at Lake Forest College, a private liberal arts university north of Chicago, she happened to pick up a magazine. 

Kafui Dzirasa, MD, PhD, and Cagla Eroglu, PhD, have been named Howard Hughes Medical Institute (HHMI) investigators. HHMI provides its researchers with long-term flexible funding that gives them the freedom to explore and, if necessary, change direction. Becoming a HHMI investigator is a tremendous scientific achievement.